From virtual sequence to expressed protein in as little as 3 weeks.
Combining a decade of HTP gene synthesis experience with the DNA2.0 suite
of proprietary machine learning-based optimization tools leads to
fast, accurate, quality protein expression in HEK and CHO cells.
DNA2.0 Acquires MIGS to Add Antibody Production Capabilities
DNA2.0 Inc. announced that it has entered into a definitive asset purchase agreement
to acquire substantially all of the assets of MIGS LLC.